CN111533680A - Folium Mori extract and folium Mori multicomponent mixture with blood sugar lowering effect prepared from the same - Google Patents
Folium Mori extract and folium Mori multicomponent mixture with blood sugar lowering effect prepared from the same Download PDFInfo
- Publication number
- CN111533680A CN111533680A CN202010470759.1A CN202010470759A CN111533680A CN 111533680 A CN111533680 A CN 111533680A CN 202010470759 A CN202010470759 A CN 202010470759A CN 111533680 A CN111533680 A CN 111533680A
- Authority
- CN
- China
- Prior art keywords
- extract
- mulberry leaf
- ethanol solution
- extraction
- mulberry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 108
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 210000004369 blood Anatomy 0.000 title abstract description 8
- 239000008280 blood Substances 0.000 title abstract description 8
- 230000000694 effects Effects 0.000 title description 5
- 240000000249 Morus alba Species 0.000 claims abstract description 191
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 191
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 160
- 238000000605 extraction Methods 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 59
- 150000004676 glycans Chemical class 0.000 claims abstract description 51
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 51
- 239000005017 polysaccharide Substances 0.000 claims abstract description 51
- 230000002378 acidificating effect Effects 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract 6
- 229930003944 flavone Natural products 0.000 claims abstract 6
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract 6
- 235000011949 flavones Nutrition 0.000 claims abstract 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract 6
- 238000000746 purification Methods 0.000 claims description 31
- 239000003480 eluent Substances 0.000 claims description 23
- 238000002481 ethanol extraction Methods 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 23
- 229920005989 resin Polymers 0.000 claims description 23
- 238000011068 loading method Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 12
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 9
- 239000003729 cation exchange resin Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 239000003456 ion exchange resin Substances 0.000 claims description 5
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000012264 purified product Substances 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000001603 reducing effect Effects 0.000 abstract description 3
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 191
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 95
- 239000000243 solution Substances 0.000 description 47
- 229930003935 flavonoid Natural products 0.000 description 46
- 150000002215 flavonoids Chemical class 0.000 description 46
- 235000017173 flavonoids Nutrition 0.000 description 46
- 241000700159 Rattus Species 0.000 description 26
- 230000001965 increasing effect Effects 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- 206010012601 diabetes mellitus Diseases 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 6
- 206010022489 Insulin Resistance Diseases 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 6
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 6
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 6
- 235000005493 rutin Nutrition 0.000 description 6
- 229960004555 rutoside Drugs 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 238000004042 decolorization Methods 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 230000003544 deproteinization Effects 0.000 description 4
- 210000004153 islets of langerhan Anatomy 0.000 description 4
- 239000011344 liquid material Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000014777 Adipokines Human genes 0.000 description 3
- 108010078606 Adipokines Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 208000017170 Lipid metabolism disease Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000478 adipokine Substances 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 102000011690 Adiponectin Human genes 0.000 description 2
- 108010076365 Adiponectin Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000001434 glomerular Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000005084 renal tissue Anatomy 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- HDPISCIDKUMRDI-UHFFFAOYSA-M N(=O)[O-].[Na+].[N+](=O)([O-])[O-].[Al+3] Chemical compound N(=O)[O-].[Na+].[N+](=O)([O-])[O-].[Al+3] HDPISCIDKUMRDI-UHFFFAOYSA-M 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 235000006650 Syzygium cordatum Nutrition 0.000 description 1
- 240000005334 Syzygium guineense Species 0.000 description 1
- 235000006651 Syzygium guineense Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 239000012916 chromogenic reagent Substances 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 229930000732 piperidine alkaloid Natural products 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于中药提取领域,具体涉及一种桑叶提取物及其制得的具有降血糖作用的桑叶多组分混合物。The invention belongs to the field of traditional Chinese medicine extraction, in particular to a mulberry leaf extract and the prepared mulberry leaf multi-component mixture with hypoglycemic effect.
背景技术Background technique
桑叶,为桑科桑属植物桑树(Morus alba L.)的叶子,其含有人体必需的氨基酸、维生素、矿物质等营养素及黄酮类、生物碱、多糖类、多酚类等多种生物活性成分。其中包括一种多羟基生物碱——1-脱氧野尻霉素(1-deoxynojirimycin,DNJ),它可以同小肠中的麦芽糖酶、蔗糖酶和乳糖酶等双糖苷酶结合,使双糖不能进一步分解为单糖被机体吸收,从而明显抑制餐后血糖急剧升高的现象,延缓糖尿病的发生与发展。此外,根据文献“桑叶多组分协同降血糖作用,王德萍、江岩等”记载,桑叶多糖、黄酮、DNJ混合物可通过减轻糖尿病小鼠体内氧化损伤,修复受损胰岛细胞、改善机体胰岛素效应细胞的抵抗作用,达到协同降血糖效应。因此,有效的从桑叶中提取出DNJ,对制备治疗糖尿病的药物具有非常重要的价值。Mulberry leaves are the leaves of Morus alba L., which contains essential amino acids, vitamins, minerals and other nutrients and flavonoids, alkaloids, polysaccharides, polyphenols and other biological Active ingredient. These include a polyhydroxyalkaloid, 1-deoxynojirimycin (DNJ), which binds to disaccharides such as maltase, sucrase, and lactase in the small intestine, preventing further breakdown of disaccharides Because the monosaccharide is absorbed by the body, it obviously inhibits the phenomenon of sharp rise in blood sugar after meals, and delays the occurrence and development of diabetes. In addition, according to the document "Multi-component synergistic hypoglycemic effect of mulberry leaves, Wang Deping, Jiang Yan, etc.", the mixture of mulberry leaf polysaccharides, flavonoids, and DNJ can reduce oxidative damage in diabetic mice, repair damaged islet cells, and improve the body's insulin. The resistance of effector cells to achieve a synergistic hypoglycemic effect. Therefore, effectively extracting DNJ from mulberry leaves has very important value for preparing medicines for treating diabetes.
目前,有关DNJ提取工艺的研究报道较少,现有提取工艺主要有微波辅助法、稀酸提取法、超声波辅助法。文献“正交优化桑叶中1-脱氧野尻霉素酸水提取的工艺”公开了一种用酸性水溶液提取桑叶中DNJ的方法,在其最佳工艺下:桑叶粉末粒度60目、提取温度55℃、pH=3盐酸溶液、料液比为1:20(g/mL)、提取时间为1.5h,DNJ得率为0.062%,纯度为19.7%。文献“超声波辅助提取桑叶中1-脱氧野尻霉素工艺的响应面法优化”公开了一种以水为溶剂的超声波辅助提取方法,在其最佳提取工艺条件下:提取时间为60min、提取温度为75℃、超声功率为350W、液料比为16mL/g,DNJ最大提取量为1.873mg/g。At present, there are few research reports on the extraction process of DNJ. The existing extraction processes mainly include microwave-assisted method, dilute acid extraction method, and ultrasonic-assisted method. The document "Orthogonal optimization of 1-deoxynojirimycin acid-water extraction process from mulberry leaves" discloses a method for extracting DNJ from mulberry leaves with an acidic aqueous solution. The temperature is 55°C, the pH=3 hydrochloric acid solution, the material-liquid ratio is 1:20 (g/mL), the extraction time is 1.5h, the yield of DNJ is 0.062%, and the purity is 19.7%. The document "Optimization of Response Surface Method for Ultrasonic-assisted Extraction of 1-Deoxynojirimycin in Mulberry Leaves" discloses an ultrasonic-assisted extraction method using water as a solvent. The temperature was 75℃, the ultrasonic power was 350W, the liquid-material ratio was 16mL/g, and the maximum extraction amount of DNJ was 1.873mg/g.
上述提取方法均采用水作为提取溶剂,增加了后处理时除去溶剂的难度,不适应大规模生产;而且上述方法所得桑叶提取物中DNJ得率较低,增加了生产成本。因此,亟需一种能够提高桑叶提取物中DNJ的提取率和纯度的提取工艺。The above extraction methods all use water as the extraction solvent, which increases the difficulty of removing the solvent during post-processing, and is not suitable for large-scale production; and the DNJ yield in the mulberry leaf extract obtained by the above method is relatively low, which increases the production cost. Therefore, there is an urgent need for an extraction process that can improve the extraction rate and purity of DNJ in mulberry leaf extracts.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种桑叶DNJ提取物及其制得的具有降血糖作用的桑叶多组分混合物。The purpose of the present invention is to provide a mulberry leaf DNJ extract and the prepared mulberry leaf multi-component mixture with hypoglycemic effect.
本发明提供了一种桑叶DNJ提取物,它是通过以下方法制得的:以桑叶为原料,利用酸性的乙醇溶液提取,即得;所述乙醇溶液浓度为65%~75%,乙醇溶液与桑叶的体积质量比为15~30mL/g。The invention provides a DNJ extract of mulberry leaves, which is prepared by the following method: taking mulberry leaves as raw materials and extracting with an acidic ethanol solution; the concentration of the ethanol solution is 65% to 75%, and the ethanol solution The volume-to-mass ratio of the solution to the mulberry leaves is 15-30 mL/g.
进一步地,所述酸性的乙醇溶液的pH为1~3,乙醇溶液浓度为70%~71%,乙醇溶液与桑叶的体积质量比为20~26mL/g,所述桑叶为粉碎后过60目筛的桑叶粉末;Further, the pH of the acidic ethanol solution is 1 to 3, the concentration of the ethanol solution is 70% to 71%, and the volume-to-mass ratio of the ethanol solution to the mulberry leaves is 20 to 26 mL/g, and the mulberry leaves are processed after being pulverized. 60 mesh mulberry leaf powder;
和/或,所述提取时,提取温度为45~65℃,优选为50~61℃。And/or, during the extraction, the extraction temperature is 45-65°C, preferably 50-61°C.
进一步地,所述提取方法为浸提法,包括以下步骤:以桑叶为原料,用pH为1~3的乙醇溶液提取;所述乙醇溶液浓度为70%~71%,提取温度为60~61℃,乙醇溶液与桑叶的体积质量比为20~21mL/g,提取次数为1~2次,提取时间为每次148~150min。Further, the extraction method is a leaching method, which includes the following steps: using mulberry leaves as raw materials, extracting with an ethanol solution with a pH of 1-3; the concentration of the ethanol solution is 70%-71%, and the extraction temperature is 60- 61° C., the volume-to-mass ratio of the ethanol solution and the mulberry leaves is 20-21 mL/g, the extraction times are 1-2 times, and the extraction time is 148-150 min each time.
进一步地,所述提取方法为超声波辅助酸性乙醇浸提法,包括以下步骤:以桑叶为原料,用pH为2~3的乙醇溶液在功率为320~322W的超声波下提取;所述乙醇溶液浓度为70%,提取温度为50℃,乙醇溶液与桑叶的体积质量比为20mL/g,提取次数为1~2次,提取时间为每次30~31min。Further, the extraction method is an ultrasonic-assisted acidic ethanol extraction method, which includes the following steps: using mulberry leaves as raw materials, extracting with an ethanol solution with a pH of 2-3 under ultrasonic waves with a power of 320-322W; the ethanol solution The concentration is 70%, the extraction temperature is 50°C, the volume-to-mass ratio of the ethanol solution and the mulberry leaves is 20mL/g, the extraction times are 1-2 times, and the extraction time is 30-31min each time.
进一步地,所述提取方法为微波辅助酸性乙醇浸提法,包括以下步骤:以桑叶为原料,用pH为2~3的乙醇溶液在功率为300~306W的微波下提取;所述乙醇溶液浓度为70%,乙醇溶液与桑叶的体积质量比为25~26mL/g,提取次数为1~2次,提取时间为每次70s。Further, the extraction method is a microwave-assisted acidic ethanol extraction method, which includes the following steps: using mulberry leaves as raw materials, extracting with an ethanol solution with a pH of 2-3 under a microwave with a power of 300-306W; the ethanol solution The concentration is 70%, the volume-to-mass ratio of the ethanol solution and the mulberry leaves is 25-26 mL/g, the extraction times are 1-2 times, and the extraction time is 70s each time.
进一步地,所述方法还包括纯化步骤,纯化方法为:将提取所得产物经过大孔树脂和/或离子交换树脂纯化;优选的,所述大孔树脂为NKA-9大孔树脂,所述离子交换树脂为001×7阳离子交换树脂。Further, the method further includes a purification step, and the purification method is as follows: the product obtained by extraction is purified by a macroporous resin and/or an ion exchange resin; preferably, the macroporous resin is NKA-9 macroporous resin, and the ion The exchange resin is 001×7 cation exchange resin.
进一步地,经过大孔树脂纯化时,上样条件如下:上样浓度为1.5mg/mL,pH=8,上样流速为1.5BV/h;洗脱条件如下:洗脱剂为75%乙醇,洗脱剂流速为2BV/h;Further, when the macroporous resin was purified, the loading conditions were as follows: the loading concentration was 1.5 mg/mL, pH=8, and the loading flow rate was 1.5 BV/h; the elution conditions were as follows: the eluent was 75% ethanol, The eluent flow rate is 2BV/h;
和/或,经过离子交换树脂纯化时,上样条件如下:上样浓度为0.8mg/mL,pH=2,上样流速为1.5BV/h;洗脱条件如下:洗脱剂为1mol/L氨水,洗脱剂流速为1BV/h。And/or, when purified by ion exchange resin, the sample loading conditions are as follows: the sample loading concentration is 0.8 mg/mL, pH=2, and the sample loading flow rate is 1.5 BV/h; the elution conditions are as follows: the eluent is 1 mol/L Ammonia, the eluent flow rate is 1BV/h.
本发明还提供了一种桑叶多组分混合物,所述桑叶多组分混合物是将上述桑叶DNJ提取物与桑叶黄酮提取物、桑叶多糖提取物混合后所得;优选的,所述桑叶多组分混合物中,DNJ、黄酮、多糖的重量比为1:6:8。The present invention also provides a multi-component mixture of mulberry leaves, the multi-component mixture of mulberry leaves is obtained by mixing the above-mentioned DNJ extract of mulberry leaves, flavonoid extracts of mulberry leaves, and polysaccharide extracts of mulberry leaves; preferably, the In the multi-component mixture of mulberry leaves, the weight ratio of DNJ, flavonoids and polysaccharides is 1:6:8.
进一步地,所述桑叶黄酮提取物是通过以下方法制得的:以桑叶为原料,利用乙醇溶液提取,即得;所述乙醇溶液浓度为70%,提取温度为88℃,乙醇溶液与桑叶的体积质量比为30mL/g,提取时间为2.5h;Further, the mulberry leaf flavonoid extract is prepared by the following method: using mulberry leaf as a raw material and extracting it with an ethanol solution; the concentration of the ethanol solution is 70%, the extraction temperature is 88°C, and the ethanol solution and The volume-to-mass ratio of mulberry leaves was 30mL/g, and the extraction time was 2.5h;
或,所述桑叶黄酮提取物是通过以下方法制得的:以桑叶为原料,用乙醇溶液在功率为126W的超声波下提取,即得;所述乙醇溶液浓度为51%,提取温度为70℃,乙醇溶液与桑叶的体积质量比为25mL/g,提取时间为36min;Or, the mulberry leaf flavonoid extract is prepared by the following method: taking mulberry leaf as raw material, extracting with ethanol solution under the ultrasonic wave with a power of 126W, and obtaining; the concentration of the ethanol solution is 51%, and the extraction temperature is At 70°C, the volume-to-mass ratio of ethanol solution and mulberry leaves was 25mL/g, and the extraction time was 36min;
和/或,所述桑叶多糖提取物是通过以下方法制得的:以桑叶为原料,用水提取,即得;所述提取温度为82℃,水与桑叶的体积质量比为17mL/g,提取时间为74min。And/or, the mulberry leaf polysaccharide extract is prepared by the following method: taking mulberry leaf as raw material, extracting with water, and obtaining; the extraction temperature is 82 ° C, and the volume-to-mass ratio of water and mulberry leaf is 17 mL/ g, the extraction time was 74 min.
进一步地,所述桑叶黄酮提取物的制备方法还包括以下纯化步骤:将提取后所得产物经过AB-8大孔树脂纯化;优选的,纯化时的上样浓度为3mg/mL,上样流速为2BV/h;洗脱剂为70%乙醇,洗脱剂流速为2BV/h;Further, the preparation method of the mulberry leaf flavonoid extract further includes the following purification steps: the product obtained after extraction is purified by AB-8 macroporous resin; preferably, the loading concentration during purification is 3 mg/mL, and the loading flow rate is is 2BV/h; the eluent is 70% ethanol, and the eluent flow rate is 2BV/h;
和/或,所述桑叶多糖提取物的制备方法还包括以下纯化步骤:将提取后所得产物用乙醇溶液沉淀;优选的,所述乙醇溶液浓度为95%,乙醇溶液体积为多糖提取物的3倍,沉淀温度为2~4℃,沉淀时间为12h;And/or, the preparation method of the mulberry leaf polysaccharide extract further includes the following purification steps: precipitating the product obtained after extraction with an ethanol solution; 3 times, the precipitation temperature is 2~4℃, and the precipitation time is 12h;
优选的,所述桑叶多糖提取物的制备方法还包括以下纯化步骤:将上述用乙醇溶液沉淀后的体系经过AB-8大孔树脂纯化;优选的,纯化时的上样浓度为0.7mg/mL,上样流速为3BV/h,洗脱剂为蒸馏水,洗脱剂流速为2BV/h。Preferably, the preparation method of the mulberry leaf polysaccharide extract further includes the following purification steps: purifying the above-mentioned system after precipitation with ethanol solution through AB-8 macroporous resin; preferably, the loading concentration during purification is 0.7 mg/ mL, the sample flow rate was 3BV/h, the eluent was distilled water, and the eluent flow rate was 2BV/h.
如无特别说明,本发明的混合溶液的浓度均为体积浓度,比如70%乙醇为体积浓度70%的乙醇溶液。Unless otherwise specified, the concentration of the mixed solution of the present invention is the volume concentration, for example, 70% ethanol is an ethanol solution with a volume concentration of 70%.
本发明提供了3种制备桑叶DNJ提取物的方法,实验证明:(1)采用酸性乙醇浸提时,在以下特定提取条件下:乙醇浓度为70~71%、提取时间为148~150min、液料比为20~21mL/g、提取温度为60~61℃,所得提取物中DNJ的得率高达2.939mg/g;(2)采用超声波辅助酸性乙醇浸提法提取时,在以下特定提取条件下:超声波功率为320~322W、提取时间为30~31min、液料比为2mL/g、提取温度为50℃,所得提取物中DNJ的得率高达3.203mg/g;(3)采用微波辅助酸性乙醇浸提法提取时,在以下特定提取条件下:微波功率为300~306W、提取时间为70s、液料比为25~26mL/g,所得提取物中DNJ的得率高达3.097mg/g。The present invention provides three methods for preparing mulberry leaf DNJ extracts. Experiments show that: (1) when acid ethanol is used for leaching, under the following specific extraction conditions: ethanol concentration of 70-71%, extraction time of 148-150min, The liquid-to-material ratio is 20-21 mL/g, and the extraction temperature is 60-61 °C, and the yield of DNJ in the obtained extract is as high as 2.939 mg/g; (2) When using ultrasonic-assisted acidic ethanol extraction, the following specific extraction Under the conditions: the ultrasonic power is 320-322W, the extraction time is 30-31min, the liquid-to-material ratio is 2mL/g, and the extraction temperature is 50℃, the yield of DNJ in the obtained extract is as high as 3.203mg/g; (3) Using microwave During the extraction with the auxiliary acidic ethanol extraction method, under the following specific extraction conditions: the microwave power is 300-306W, the extraction time is 70s, and the liquid-material ratio is 25-26mL/g, the yield of DNJ in the obtained extract is as high as 3.097mg/g g.
本发明还利用NKA-9大孔树脂、001×7阳离子交换树脂对所得桑叶DNJ提取物进行纯化,在特定的纯化条件下,显著提高了提取物中DNJ的纯度。The invention also utilizes NKA-9 macroporous resin and 001×7 cation exchange resin to purify the obtained DNJ extract of mulberry leaves, and under specific purification conditions, the purity of DNJ in the extract is significantly improved.
此外,本发明以上述方法制得的桑叶DNJ提取物为原料,与桑叶黄酮提取物、桑叶多糖提取物在特定比例下(控制DNJ:黄酮:多糖的重量比为1:6:8)混合得到的桑叶多组分混合物具有优异的降血糖作用,在制备降血糖药物中具有良好的应用前景。In addition, the present invention uses the mulberry leaf DNJ extract obtained by the above method as a raw material, and the mulberry leaf flavonoid extract and the mulberry leaf polysaccharide extract are in a specific ratio (controlling the weight ratio of DNJ: flavonoid: polysaccharide to 1:6:8 ), the multi-component mixture of mulberry leaves obtained by mixing has excellent hypoglycemic effect, and has a good application prospect in the preparation of hypoglycemic drugs.
本发明提供的提取方法操作简单、条件温和,在本发明特定的提取条件下,所得桑叶DNJ提取物中DNJ的得率和纯度显著提高。本发明的桑叶DNJ提取物在制备活性成分只含桑叶DNJ,或者包含桑叶多糖、黄酮、DNJ混合物的降血糖药物中具有很好的前景。The extraction method provided by the invention has simple operation and mild conditions, and under the specific extraction conditions of the invention, the yield and purity of DNJ in the obtained DNJ extract of mulberry leaves are significantly improved. The mulberry leaf DNJ extract of the present invention has a good prospect in preparing a hypoglycemic drug containing only mulberry leaf DNJ or a mixture of mulberry leaf polysaccharides, flavonoids and DNJ as active ingredients.
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。Obviously, according to the above-mentioned content of the present invention, according to the common technical knowledge and conventional means in the field, without departing from the above-mentioned basic technical idea of the present invention, other various forms of modification, replacement or change can also be made.
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。The above content of the present invention will be further described in detail below through the specific implementation in the form of examples. However, this should not be construed as limiting the scope of the above-mentioned subject matter of the present invention to the following examples. All technologies implemented based on the above content of the present invention belong to the scope of the present invention.
具体实施方式Detailed ways
本发明所用原料与设备均为已知产品,通过购买市售产品所得。The raw materials and equipment used in the present invention are all known products, obtained by purchasing commercially available products.
NKA-9大孔树脂购于河北沧州宝恩吸附材料科技公司,比表面积450-520,平均孔径12.5-13.5nm。NKA-9 macroporous resin was purchased from Hebei Cangzhou Baoen Adsorption Material Technology Company, with a specific surface area of 450-520 and an average pore size of 12.5-13.5nm.
将白桑(Morus alba L.)桑叶洗净阴干,用万能粉碎机粉碎,过60目筛,得桑叶粉,避光贮存,备用。White mulberry (Morus alba L.) mulberry leaves were washed and dried in the shade, pulverized with a universal pulverizer, and passed through a 60-mesh sieve to obtain mulberry leaf powder, which was stored in the dark for later use.
实施例1采用酸性乙醇浸提法提取桑叶DNJEmbodiment 1 adopts acid ethanol extraction method to extract mulberry leaf DNJ
称取2g桑叶粉置于平底烧瓶,加入42mL用盐酸调整的pH=2浓度为71%乙醇,在提取温度61℃条件下提取148min,提取2次,得到本发明的桑叶DNJ提取物1。DNJ得率为2.939(mg/g)。Weigh 2 g of mulberry leaf powder and place it in a flat-bottomed flask, add 42 mL of ethanol with pH=2 adjusted with hydrochloric acid to a concentration of 71%, extract at an extraction temperature of 61° C. for 148 min, and extract twice to obtain the mulberry leaf DNJ extract 1 of the present invention. . The DNJ yield was 2.939 (mg/g).
实施例2采用超声波辅助酸性乙醇浸提法提取桑叶DNJEmbodiment 2 adopts ultrasonic-assisted acid ethanol extraction method to extract mulberry leaf DNJ
称取2g桑叶粉置于平底烧瓶,加入40mL用盐酸调整的pH=2浓度为70%乙醇,在提取温度50℃,超声波功率为322W条件下提取31min,提取2次,得到本发明的桑叶DNJ提取物2。DNJ得率为3.203(mg/g)。Weigh 2g of mulberry leaf powder and place it in a flat-bottomed flask, add 40 mL of pH=2 concentration adjusted with hydrochloric acid to be 70% ethanol, extract for 31 min at an extraction temperature of 50° C. and an ultrasonic power of 322 W, and extract twice to obtain the mulberry of the present invention. Leaf DNJ Extract 2. The DNJ yield was 3.203 (mg/g).
实施例3采用微波辅助酸性乙醇浸提法提取桑叶DNJExample 3 Extraction of DNJ from mulberry leaves by microwave-assisted acid ethanol extraction
称取2g桑叶粉置于平底烧瓶,分别加入52mL用盐酸调整的pH=2浓度为70%乙醇,微波功率为306W条件下提取70s,提取2次,得到本发明的桑叶DNJ提取物3。DNJ得率为3.097(mg/g)。Weigh 2 g of mulberry leaf powder and place it in a flat-bottomed flask, add 52 mL of pH=2 adjusted with hydrochloric acid to 70% ethanol, extract for 70 s under the condition of 306 W microwave power, and extract twice to obtain the mulberry leaf DNJ extract 3 of the present invention. . The DNJ yield was 3.097 (mg/g).
实施例4桑叶DNJ提取物的纯化Example 4 Purification of DNJ extract of mulberry leaves
以实施例1制得的桑叶DNJ提取物1(DNJ纯度为8.2%)为粗品,采用NKA-9大孔树脂进行纯化。样品上样条件如下:上样浓度为1.5mg/mL,pH=8,流速为1.5BV/h;洗脱剂为75%乙醇,洗脱剂流速为2BV/h。The DNJ extract 1 of mulberry leaves (DNJ purity was 8.2%) prepared in Example 1 was used as the crude product, and was purified by NKA-9 macroporous resin. The sample loading conditions were as follows: the loading concentration was 1.5 mg/mL, pH=8, and the flow rate was 1.5 BV/h; the eluent was 75% ethanol, and the eluent flow rate was 2 BV/h.
经过上述纯化过程后,所得桑叶DNJ提取物的DNJ纯度从8.2%增加为28.4%,其纯度提高了3.5倍。After the above purification process, the DNJ purity of the obtained mulberry leaf DNJ extract was increased from 8.2% to 28.4%, and its purity was increased by 3.5 times.
实施例5桑叶DNJ提取物的进一步纯化Example 5 Further purification of mulberry leaf DNJ extract
以实施例4制得的纯化桑叶DNJ提取物(DNJ纯度为28.4%)为粗品,采用001×7阳离子交换树脂进一步纯化。样品上样条件如下:上样pH=2,浓度为0.8mg/mL,流速为1.5BV/h;洗脱剂为1mol/L氨水,洗脱流速为1BV/h。The purified mulberry leaf DNJ extract (DNJ purity was 28.4%) prepared in Example 4 was used as the crude product, and was further purified by 001×7 cation exchange resin. The sample loading conditions were as follows: sample loading pH=2, concentration 0.8 mg/mL, flow rate 1.5 BV/h; eluent was 1 mol/L ammonia water, elution flow rate was 1 BV/h.
经过上述进一步的纯化过程后,所得桑叶DNJ提取物的DNJ纯度从28.4%增加为70.4%,其纯度进一步提高了2.5倍。After the above-mentioned further purification process, the DNJ purity of the obtained mulberry leaf DNJ extract was increased from 28.4% to 70.4%, and its purity was further increased by 2.5 times.
实施例6采用乙醇浸提法提取桑叶黄酮Embodiment 6 adopts ethanol extraction method to extract mulberry leaf flavonoids
称取2g桑叶粉置于平底烧瓶,加入60mL浓度为70%乙醇,在提取温度88℃条件下提取2.5h,得到本发明的桑叶黄酮提取物1。黄酮得率为4.16%。2 g of mulberry leaf powder was weighed and placed in a flat-bottomed flask, 60 mL of 70% ethanol was added, and the extraction temperature was 88° C. for 2.5 hours to obtain the mulberry leaf flavonoid extract 1 of the present invention. The yield of flavonoids was 4.16%.
黄酮得率=桑叶黄酮提取物中的黄酮质量/桑叶粉质量。Flavonoid yield = flavonoid mass in mulberry leaf flavonoid extract/mulberry leaf powder mass.
实施例7采用超声波辅助乙醇浸提提取桑叶黄酮Embodiment 7 adopts ultrasonic-assisted ethanol extraction to extract mulberry leaf flavonoids
称取2g桑叶粉置于平底烧瓶,加入50mL浓度为51%乙醇,在超声温度为70℃、超声功率为126W条件下提取36min,得到本发明的桑叶黄酮提取物2。黄酮得率为3.79%。2 g of mulberry leaf powder was weighed and placed in a flat-bottomed flask, 50 mL of 51% ethanol was added, and the ultrasonic temperature was 70° C. and the ultrasonic power was 126 W and extracted for 36 min to obtain the mulberry leaf flavonoid extract 2 of the present invention. The yield of flavonoids was 3.79%.
实施例8桑叶黄酮提取物的纯化Example 8 Purification of mulberry leaf flavonoid extract
以实施例6制得的桑叶黄酮提取物1(黄酮纯度为8.49%)为粗品,采用AB-8大孔树脂进行纯化。样品上样条件如下:上样浓度为3mg/mL,流速为2BV/h;洗脱剂为70%乙醇,洗脱剂流速为2BV/h。The mulberry leaf flavonoid extract 1 (the flavonoid purity was 8.49%) prepared in Example 6 was used as the crude product, and AB-8 macroporous resin was used for purification. The sample loading conditions were as follows: the loading concentration was 3 mg/mL, and the flow rate was 2BV/h; the eluent was 70% ethanol, and the eluent flow rate was 2BV/h.
经过上述纯化过程后,桑叶黄酮提取物的黄酮纯度从8.49%增加为52.34%,其纯度提高了6.16倍。After the above purification process, the flavonoid purity of the mulberry leaf flavonoid extract was increased from 8.49% to 52.34%, and the purity was increased by 6.16 times.
采用HPLC法对上述AB-8大孔树脂纯化后的提取物进行组分分析,发现其中主要包含5个黄酮类化合物,各黄酮类化合物含量如下:绿原酸86.50mg/g、异槲皮苷60.94mg/g、紫云英苷35.12mg/g、芦丁23.75mg/g、槲皮素14.87mg/g。HPLC method was used to analyze the components of the purified extract of the above AB-8 macroporous resin, and it was found that it mainly contained 5 flavonoids, and the content of each flavonoid was as follows: chlorogenic acid 86.50 mg/g, isoquercitrin 60.94mg/g, astragaloside 35.12mg/g, rutin 23.75mg/g, quercetin 14.87mg/g.
实施例9采用水浸提乙醇沉淀法提取桑叶多糖Embodiment 9 adopts water extraction ethanol precipitation method to extract mulberry leaf polysaccharide
(1)桑叶多糖提取液的制备(1) Preparation of mulberry leaf polysaccharide extract
将桑叶粉过40目筛,石油醚脱脂。称取2g桑叶粉置于圆底烧瓶中,加入蒸馏水,在液料比为17:1mL/g,提取温度82℃,提取时间74min,提取2次的条件下提取。将所得提取液离心,收集上清液,真空浓缩3倍,得到桑叶多糖浓缩液。The mulberry leaf powder was passed through a 40-mesh sieve, and petroleum ether was degreased. Weigh 2 g of mulberry leaf powder and place it in a round-bottomed flask, add distilled water, and extract under the conditions that the liquid-to-material ratio is 17:1 mL/g, the extraction temperature is 82 °C, the extraction time is 74 min, and the extraction is performed twice. The obtained extract was centrifuged, the supernatant was collected, and concentrated in vacuo for 3 times to obtain a mulberry leaf polysaccharide concentrate.
(2)乙醇沉淀(2) Ethanol precipitation
取步骤(1)所得桑叶多糖浓缩液,加入3倍体积的95%的乙醇溶液,低温(2~4℃)静置沉淀12h,高速离心分离(3000r/min,15min),得桑叶多糖提取物,多糖得率为14.24%。Take the mulberry leaf polysaccharide concentrate obtained in step (1), add 3 times the volume of 95% ethanol solution, stand at low temperature (2~4°C) for precipitation for 12h, and separate by high-speed centrifugation (3000r/min, 15min) to obtain mulberry leaf polysaccharide Extract, polysaccharide yield was 14.24%.
多糖得率=桑叶多糖提取物中的多糖质量/桑叶粉质量。Polysaccharide yield = polysaccharide mass in mulberry leaf polysaccharide extract/mulberry leaf powder mass.
实施例10桑叶多糖的纯化Example 10 Purification of mulberry leaf polysaccharide
以实施例9制得的乙醇沉淀后的桑叶多糖提取物为粗品,采用AB-8大孔树脂进行纯化。样品上样条件如下:上样浓度为0.7mg/mL,流速为3BV/h;洗脱剂为蒸馏水,洗脱剂流速为2BV/h。The ethanol-precipitated mulberry leaf polysaccharide extract prepared in Example 9 was used as the crude product, and AB-8 macroporous resin was used for purification. The sample loading conditions were as follows: the loading concentration was 0.7 mg/mL, and the flow rate was 3BV/h; the eluent was distilled water, and the eluent flow rate was 2BV/h.
经过上述纯化过程后,所得桑叶多糖提取物的多糖纯度为32.6%,多糖得率为19.3%,多糖保留率56.5%,脱蛋白率68.4%,脱色率50.8%。After the above purification process, the polysaccharide purity of the obtained mulberry leaf polysaccharide extract was 32.6%, the polysaccharide yield was 19.3%, the polysaccharide retention rate was 56.5%, the deproteinization rate was 68.4%, and the decolorization rate was 50.8%.
实施例11桑叶多组分混合物的制备Example 11 Preparation of multi-component mixture of mulberry leaves
将实施例1~5任一个实施例制得的桑叶DNJ提取物、实施例6~8任一个实施例制得的桑叶黄酮提取物、实施例9~10任一个实施例制得的桑叶多糖提取物混合,控制DNJ:黄酮:多糖的重量比为1:6:8,得到桑叶多组分混合物。The mulberry leaf DNJ extract prepared in any one of Examples 1 to 5, the mulberry leaf flavonoid extract prepared in any one of Examples 6 to 8, and the mulberry leaf prepared in any one of Examples 9 to 10 were used. The leaf polysaccharide extracts were mixed, and the weight ratio of DNJ: flavonoids: polysaccharide was controlled to be 1:6:8 to obtain a multi-component mixture of mulberry leaves.
以下通过实验例证明本发明的有益效果。The beneficial effects of the present invention are demonstrated below through experimental examples.
实验例1桑叶DNJ提取物中DNJ含量及纯度的测试Experimental Example 1 Test of DNJ content and purity in DNJ extract of mulberry leaves
1.1试剂的配制1.1 Preparation of reagents
(1)DNJ标准溶液配制:准确称取5mg DNJ标准品于烧杯中,加少量0.05mol/L盐酸溶解,加入一定蒸馏水,移入50mL容量瓶,冲洗三次烧杯和玻璃棒一并移入容量瓶,定容至50mL,得0.1mg/mL的DNJ标准溶液。(1) Preparation of DNJ standard solution: Accurately weigh 5mg of DNJ standard product in a beaker, add a small amount of 0.05mol/L hydrochloric acid to dissolve, add a certain amount of distilled water, transfer it into a 50mL volumetric flask, rinse the beaker three times and move it into the volumetric flask together with the glass rod. Volume to 50mL to obtain 0.1mg/mL DNJ standard solution.
(2)wagner试剂配制:称取l g I2及10g KI,于烧杯中,加入少量蒸馏水溶解,加少量醋酸加热,用蒸馏水稀释至100mL,贮存于棕色广口瓶中备用。(2) Preparation of wagner reagent: Weigh 1 g I 2 and 10 g KI, add a small amount of distilled water to dissolve in a beaker, add a small amount of acetic acid to heat, dilute to 100 mL with distilled water, and store in a brown wide-mouth bottle for later use.
1.2确定特异吸收波长1.2 Determine the specific absorption wavelength
DNJ属于一种哌啶生物碱,在酸性条件下与wagner试剂生成络合物,可以在紫外条件下检出。取0.l mg/mL DNJ标准溶液5mL于25ml容量瓶中,加入少量wagner试剂,于紫外分光光度计240nm-420nm波长范围内扫描,确定DNJ特异吸收波长。DNJ is a piperidine alkaloid, which forms a complex with Wagner's reagent under acidic conditions and can be detected under UV conditions. Take 5 mL of 0.1 mg/mL DNJ standard solution in a 25 mL volumetric flask, add a small amount of wagner reagent, and scan in the wavelength range of 240nm-420nm with an ultraviolet spectrophotometer to determine the specific absorption wavelength of DNJ.
1.3绘制标准曲线1.3 Draw a standard curve
分别吸取10μL、20μL、30μL、40μL、50μL的DNJ标准样品溶液,于5支不同编号的具塞试管中,各具塞试管中加入等量碘-碘化钾试剂作显色剂,加蒸馏水使样品溶液总体积为5mL,另取一支具塞试管加入等量碘-碘化钾试剂,逐渐加入蒸馏水调整溶液体积为5mL,作为空白对照。在最大吸收波长下测定各个试管溶液的吸收值,以DNJ浓度为横坐标,吸光度为纵坐标绘制标准曲线。Pipette 10 μL, 20 μL, 30 μL, 40 μL, and 50 μL of DNJ standard sample solution, respectively, into 5 test tubes with stoppers of different numbers, add an equal amount of iodine-potassium iodide reagent to each stoppered test tube as a chromogenic reagent, and add distilled water to make the sample solution The total volume is 5mL, another test tube with a stopper is added to the same amount of iodine-potassium iodide reagent, and distilled water is gradually added to adjust the solution volume to 5mL, as a blank control. The absorption value of each test tube solution was measured at the maximum absorption wavelength, and the standard curve was drawn with the DNJ concentration as the abscissa and the absorbance as the ordinate.
1.4 DNJ含量的测定1.4 Determination of DNJ content
(1)取一定量的样品溶液于25mL容量瓶中,加入wagner试剂,定容,振荡,在最大吸收波长下测定其吸光度,由标准曲线算出其对应的样品浓度,并按照下式计算DNJ得率(即DNJ含量):(1) Take a certain amount of sample solution in a 25mL volumetric flask, add wagner reagent, constant volume, shake, measure its absorbance at the maximum absorption wavelength, calculate the corresponding sample concentration from the standard curve, and calculate DNJ according to the following formula: Rate (i.e. DNJ content):
C:标准曲线DNJ浓度(μg/mL)C: standard curve DNJ concentration (μg/mL)
n:稀释倍数n: dilution factor
V:样液体积(mL)V: sample volume (mL)
W:桑叶质量(g)W: mulberry leaf mass (g)
1.5 DNJ纯度的测定1.5 Determination of DNJ purity
取待测的桑叶DNJ提取物,按照下式进行计算:Take the mulberry leaf DNJ extract to be tested and calculate according to the following formula:
C:标准曲线DNJ浓度(mg/mL)C: standard curve DNJ concentration (mg/mL)
n:稀释倍数n: dilution factor
V:样液体积(mL)V: sample volume (mL)
M:待测样品烘干后重量(g)M: weight of the sample to be tested after drying (g)
1.6实验结果1.6 Experimental results
采用上述方法,得DNJ的标准曲线:y=0.1641x-0.0013,R2=0.9991。分别计算出各实施例中DNJ得率,如表1所示。本发明采用超声波辅助酸性乙醇法提取DNJ的得率为3.203mg/g,较酸性乙醇法得率提高了9.0%;采用微波辅助酸性乙醇法提取DNJ的得率为3.097mg/g,较酸性乙醇法得率提高了5.4%。Using the above method, the standard curve of DNJ was obtained: y=0.1641x-0.0013, R 2 =0.9991. The DNJ yields in each example were calculated respectively, as shown in Table 1. The invention adopts the ultrasonic-assisted acidic ethanol method to extract DNJ, and the yield is 3.203 mg/g, which is 9.0% higher than that of the acidic ethanol method; The method yield increased by 5.4%.
如表2所示,实施例4经过NKA-9大孔树脂纯化后的桑叶DNJ提取物的DNJ纯度从8.2%增加为28.4%,其纯度提高了3.5倍。实施例5经过001×7阳离子交换树脂进一步纯化后的桑叶DNJ提取物的DNJ纯度从28.4%增加为70.4%,其纯度进一步提高了2.5倍。As shown in Table 2, the DNJ purity of the DNJ extract of mulberry leaves purified by NKA-9 macroporous resin in Example 4 was increased from 8.2% to 28.4%, and the purity was increased by 3.5 times. Example 5 The DNJ purity of the DNJ extract of mulberry leaves after further purification by 001×7 cation exchange resin was increased from 28.4% to 70.4%, and the purity was further increased by 2.5 times.
表1各实施例DNJ得率计算结果Calculation results of DNJ yield of each embodiment of table 1
表2各实施例DNJ纯度计算结果Calculation result of DNJ purity of each embodiment of table 2
实验例2桑叶黄酮提取物中黄酮含量及纯度的测试Experimental example 2 Test of flavonoid content and purity in mulberry leaf flavonoid extract
2.1硝酸铝-亚硝酸钠法测定原理2.1 Determination principle of aluminum nitrate-sodium nitrite method
黄酮类化合物与硝酸铝反应之后,形成的黄酮铝盐络合离子呈黄色,其颜色的深浅与黄酮含量成一定的比例关系,可以定量测定。After the flavonoids react with aluminum nitrate, the flavonoid-aluminum salt complex ions formed are yellow, and the color depth is proportional to the flavonoid content, which can be quantitatively determined.
2.2绘制标准曲线2.2 Draw the standard curve
称取10.00mg芦丁标准品,溶于65%乙醇溶液,定容至50mL,配成0.2mg/mL的芦丁标准溶液。分别吸取0、0.5mL、1.0mL、2.0mL、3.0mL、4.0mL芦丁标准溶液于10mL容量瓶中,加0.5mL NaNO2(1:20)溶液,摇匀放置6min,加0.5mL Al(NO3)3(1:10)溶液,摇匀放置6min,加4mL 1mol/L的NaOH溶液,65%乙醇溶液定容,摇匀放置10~20min,以第一管溶液作为空白对照,于510nm波长下测定吸光度。以芦丁标准溶液浓度为横坐标,以吸光度为纵坐标,绘制标准曲线。Weigh 10.00 mg of rutin standard, dissolve it in 65% ethanol solution, dilute to 50 mL, and prepare a 0.2 mg/mL rutin standard solution. Pipette 0, 0.5 mL, 1.0 mL, 2.0 mL, 3.0 mL, and 4.0 mL of rutin standard solution into a 10 mL volumetric flask, add 0.5 mL of NaNO 2 (1:20) solution, shake well for 6 min, add 0.5 mL of Al ( NO 3 ) 3 (1:10) solution, shake well for 6 minutes, add 4 mL of 1 mol/L NaOH solution, 65% ethanol solution to volume, shake well and place for 10-20 minutes, take the first tube of solution as blank control, at 510 nm Absorbance was measured at the wavelength. Draw the standard curve with the concentration of rutin standard solution as the abscissa and the absorbance as the ordinate.
2.3桑叶黄酮含量测定2.3 Determination of flavonoids in mulberry leaves
取待测样品溶液0.5mL于容量瓶中,按绘制标准曲线的方法操作,按公式计算黄酮含量(即黄酮得率)。公式如下:Take 0.5mL of the sample solution to be tested in a volumetric flask, operate according to the method of drawing a standard curve, and calculate the flavonoid content (ie the flavonoid yield) according to the formula. The formula is as follows:
式中:C—标准曲线黄酮浓度(mg/mL)In the formula: C—standard curve flavonoid concentration (mg/mL)
n—稀释倍数n—dilution factor
V—样液体积(mL)V—sample volume (mL)
W—桑叶质量(g)W—mulberry leaf mass (g)
2.4桑叶黄酮纯度测定2.4 Determination of the purity of mulberry leaf flavonoids
取待测的桑叶黄酮提取物,按以下公式计算黄酮的纯度。Take the mulberry leaf flavonoid extract to be tested, and calculate the purity of flavonoids according to the following formula.
式中:C—标准曲线黄酮浓度(mg/mL)In the formula: C—standard curve flavonoid concentration (mg/mL)
n—稀释倍数n—dilution factor
V—样液体积(mL)V—sample volume (mL)
M—提取物冷冻干燥后重量(g)M—weight of the extract after freeze-drying (g)
2.5实验结果2.5 Experimental results
采用上述方法,得芦丁的标准曲线:A(y)=10.949(x)+0.0138,R2=0.9991。计算出实施例6所得提取物黄酮得率为4.16%,实施例7所得提取物黄酮得率为3.79%。Using the above method, the standard curve of rutin was obtained: A(y)=10.949(x)+0.0138, R 2 =0.9991. The flavonoid yield of the extract obtained in Example 6 was calculated to be 4.16%, and the flavonoid yield of the extract obtained in Example 7 was 3.79%.
实施例8经AB-8大孔树脂纯化后的黄酮提取物,黄酮纯度从8.49%增加为52.34%,其纯度提高了6.16倍。In the flavonoid extract purified by AB-8 macroporous resin in Example 8, the purity of flavonoids increased from 8.49% to 52.34%, and the purity was increased by 6.16 times.
实验例3桑叶多糖提取物中多糖含量及纯度的测试Experimental Example 3 Test of polysaccharide content and purity in mulberry leaf polysaccharide extract
3.1多糖保留率测定3.1 Determination of polysaccharide retention rate
采用苯酚-硫酸法测定多糖含量,按以下计算多糖保留率。The polysaccharide content was determined by the phenol-sulfuric acid method, and the polysaccharide retention rate was calculated as follows.
3.2脱蛋白率测定3.2 Determination of deproteinization rate
采用考马斯亮蓝法测定蛋白质含量。考马斯亮蓝G-250的配制:称取100mg考马斯亮蓝G-250,溶于50mL 90%乙醇中,加入85%(W/V)的磷酸100mL,最后用蒸馏水定容到1000mL。配制100μg/mL的牛血清蛋白,分别取0mL,0.1mL,0.2mL,0.3mL,0.4mL,0.5mL,0.6mL于试管中,用0.15M NaCl溶液补至1mL后加入5mL事先配制好的考马斯亮蓝溶液,静置10min后于595nm测定吸光值,绘制标准曲线。按以下公式计算脱蛋白率。The protein content was determined by the Coomassie brilliant blue method. Preparation of Coomassie Brilliant Blue G-250: Weigh 100 mg of Coomassie Brilliant Blue G-250, dissolve in 50 mL of 90% ethanol, add 100 mL of 85% (W/V) phosphoric acid, and finally dilute to 1000 mL with distilled water. To prepare 100μg/mL bovine serum albumin, take 0mL, 0.1mL, 0.2mL, 0.3mL, 0.4mL, 0.5mL, and 0.6mL in test tubes, add 0.15M NaCl solution to 1mL, and add 5mL of pre-prepared test tubes. Mass brilliant blue solution, after standing for 10min, measure the absorbance at 595nm, and draw a standard curve. Calculate the deproteinization rate according to the following formula.
3.3脱色率测定3.3 Determination of decolorization rate
配制浓度为1%的桑叶粗多糖溶液,对其进行可见-紫外全波长扫描,结果表明,该溶液无最大吸收波长。根据互补色原理可知,溶液呈现的颜色是它吸收光的互补色,由于多糖溶液脱色前后稀释后均为橙黄色,所以溶液主要吸收蓝色波段可见光。因此选择处于该波段中心的450nm波长为检测波长,测定溶液的吸光度。并按以下公式计算脱色率。The mulberry leaf crude polysaccharide solution with a concentration of 1% was prepared, and the visible-ultraviolet full-wavelength scanning was performed on it. The results showed that the solution had no maximum absorption wavelength. According to the principle of complementary color, the color of the solution is the complementary color that it absorbs light. Since the polysaccharide solution is orange-yellow before and after decolorization and after dilution, the solution mainly absorbs visible light in the blue band. Therefore, the wavelength of 450 nm in the center of this band is selected as the detection wavelength, and the absorbance of the solution is measured. And calculate the decolorization rate according to the following formula.
3.4纯化后桑叶多糖纯度的测定3.4 Determination of the purity of mulberry leaf polysaccharide after purification
取待测桑叶多糖提取物,按照以下公式进行计算多糖纯度:Take the mulberry leaf polysaccharide extract to be tested, and calculate the polysaccharide purity according to the following formula:
式中:C—标准曲线多糖浓度(mg/mL)In the formula: C—standard curve polysaccharide concentration (mg/mL)
n—稀释倍数n—dilution factor
V—样液体积(mL)V—sample volume (mL)
M—提取物冷冻干燥后重量(g)M—weight of the extract after freeze-drying (g)
3.5实验结果3.5 Experimental results
经过AB-8大孔树脂纯化过程后,实施例10所得桑叶多糖提取物的多糖纯度为32.6%,多糖得率为19.3%,多糖保留率56.5%,脱蛋白率68.4%,脱色率50.8%。After the AB-8 macroporous resin purification process, the polysaccharide purity of the mulberry leaf polysaccharide extract obtained in Example 10 was 32.6%, the polysaccharide yield was 19.3%, the polysaccharide retention rate was 56.5%, the deproteinization rate was 68.4%, and the decolorization rate was 50.8%. .
实验例4采用酸性乙醇提取桑叶DNJ的工艺筛选Experimental Example 4 Process Screening of Extracting Mulberry Leaf DNJ with Acidic Ethanol
1、实验方法1. Experimental method
参照实施例1的工艺,按照表3改变乙醇浓度、提取时间、液料比、提取温度,分别提取桑叶DNJ提取物,按照实验例1的方法计算各工艺下的DNJ得率。每个工艺条件下重复5次,取平均值。With reference to the process of Example 1, the ethanol concentration, extraction time, liquid-to-material ratio, and extraction temperature were changed according to Table 3, and the DNJ extract of mulberry leaves was extracted respectively, and the DNJ yield under each process was calculated according to the method of Experimental Example 1. Each process condition was repeated 5 times, and the average value was taken.
2、实验结果2. Experimental results
结果如表3所示,可以看出,利用酸性乙醇提取桑叶时,当乙醇浓度为70~71%、提取时间为148~150min、液料比为20~21mL/g、提取温度为60~61℃时,所得提取物中DNJ的得率最高。The results are shown in Table 3. It can be seen that when using acidic ethanol to extract mulberry leaves, when the ethanol concentration is 70-71%, the extraction time is 148-150 min, the liquid-material ratio is 20-21 mL/g, and the extraction temperature is 60- At 61°C, the yield of DNJ in the obtained extract was the highest.
表3酸性乙醇法提取桑叶DNJ的工艺筛选实验结果Table 3 Technological screening experiment results of extracting DNJ from mulberry leaves by acid ethanol method
实验例5采用超声波辅助酸性乙醇浸提法提取桑叶DNJ的工艺筛选Experimental Example 5. Screening of the extraction of DNJ from mulberry leaves by ultrasonic-assisted acid ethanol extraction
1、实验方法1. Experimental method
参照实施例2的工艺,按照表4改变超声波功率、提取时间、液料比、提取温度,分别提取桑叶DNJ提取物,按照实验例1的方法计算各工艺下的DNJ得率。With reference to the process of Example 2, the ultrasonic power, extraction time, liquid-to-material ratio, and extraction temperature were changed according to Table 4, and the mulberry leaf DNJ extract was extracted respectively, and the DNJ yield under each process was calculated according to the method of Experimental Example 1.
2、实验结果2. Experimental results
结果如表4所示,可以看出,利用超声波辅助酸性乙醇浸提法提取桑叶时,当超声波功率为320~322W、提取时间为30~31min、液料比为20mL/g、提取温度为50℃时,所得提取物中DNJ的得率最高。The results are shown in Table 4. It can be seen that when the mulberry leaves are extracted by ultrasonic-assisted acid ethanol extraction, when the ultrasonic power is 320-322 W, the extraction time is 30-31 min, the liquid-to-material ratio is 20 mL/g, and the extraction temperature is At 50℃, the yield of DNJ in the obtained extract was the highest.
表4超声波辅助酸性乙醇浸提法提取桑叶DNJ的工艺筛选实验结果Table 4 The results of the process screening experiment for the extraction of DNJ from mulberry leaves by ultrasonic-assisted acid ethanol extraction
实验例6采用微波辅助酸性乙醇浸提法提取桑叶DNJ的工艺筛选Experimental Example 6 Process Screening of Extraction of Mulberry Leaf DNJ by Microwave-Assisted Acidic Ethanol Extraction
1、实验方法1. Experimental method
参照实施例3的工艺,按照表5改变微波功率、提取时间、液料比,分别提取桑叶DNJ提取物,按照实验例1的方法计算各工艺下的DNJ得率。With reference to the process of Example 3, the microwave power, extraction time, and liquid-to-material ratio were changed according to Table 5, and the DNJ extract of mulberry leaves was extracted respectively, and the DNJ yield under each process was calculated according to the method of Experimental Example 1.
2、实验结果2. Experimental results
结果如表5所示,可以看出,利用微波辅助酸性乙醇浸提法提取桑叶时,当微波功率为300~306W、提取时间为70s、液料比为25~26mL/g时,所得提取物中DNJ的得率最高。The results are shown in Table 5. It can be seen that when the mulberry leaves are extracted by the microwave-assisted acidic ethanol extraction method, when the microwave power is 300-306 W, the extraction time is 70 s, and the liquid-material ratio is 25-26 mL/g, the obtained extraction Among them, the yield of DNJ was the highest.
表5微波辅助酸性乙醇浸提法提取桑叶DNJ的工艺筛选实验结果Table 5 The results of the process screening experiment of extracting DNJ from mulberry leaves by microwave-assisted acid ethanol extraction
实验例7桑叶多组分混合物的降血糖作用表征Experimental Example 7 Characterization of hypoglycemic effect of multi-component mixture of mulberry leaves
1、实验方法1. Experimental method
实验药物:实施例11制得的桑叶多组分混合物;阳性药物为二甲双胍。Experimental drug: the multi-component mixture of mulberry leaves prepared in Example 11; the positive drug is metformin.
建立糖尿病大鼠模型:取健康雄性SD大鼠,高脂饲料喂饲6周后,一次性腹腔注射链脲佐菌素溶液(30mg/kg·BW),72h后测定空腹血糖,以空腹血糖≥11.1mmol/L指标确定糖尿病大鼠造模成功。Establishment of diabetic rat model: healthy male SD rats were taken, fed with high-fat diet for 6 weeks, and then intraperitoneally injected with streptozotocin solution (30 mg/kg·BW) at one time. The 11.1mmol/L index confirmed that the diabetic rat model was successful.
将桑叶多组分混合物(100mg/kg·d·BW)或阳性药物(185mg/kg·d·BW)喂饲(灌胃)建模后的SD雄性大鼠,共计治疗6周。以喂饲相同体积生理盐水的建模后的SD雄性大鼠作为模型对照组,以喂饲相同体积生理盐水的正常SD大鼠作为空白对照组。Modeled SD male rats were fed (gavage) with mulberry leaf multi-component mixture (100 mg/kg·d·BW) or positive drug (185 mg/kg·d·BW) for a total of 6 weeks of treatment. Modeled SD male rats fed the same volume of normal saline were used as the model control group, and normal SD rats fed the same volume of normal saline were used as the blank control group.
治疗6周后,测试大鼠血糖水平、胰岛素水平;测试大鼠血清中的总胆固醇、甘油三酯、LDL-C及HDL-C;测试大鼠血清中的抗氧化酶:超氧化物歧化酶SOD、谷胱甘肽过氧化物酶GSH-Px、过氧化氢酶CAT的活性,过氧化脂质丙二醛MDA水平;测试大鼠血清中的脂肪细胞因子:游离脂肪酸、TNF-α、瘦素和炎症因子C反应蛋白水平;测试大鼠血清中的肾功指标尿素氮、肌酐水平;观察大鼠肝脏组织、胰腺组织、肾组织切片。After 6 weeks of treatment, test the blood sugar level and insulin level of the rat; test the total cholesterol, triglyceride, LDL-C and HDL-C in the serum of the rat; test the antioxidant enzyme in the serum of the rat: superoxide dismutase Activity of SOD, glutathione peroxidase GSH-Px, catalase CAT, lipid peroxidized malondialdehyde MDA level; test adipocytokines in rat serum: free fatty acid, TNF-α, lean The serum levels of urea nitrogen and creatinine were measured, and the levels of urea nitrogen and creatinine in the serum of the rats were measured; the liver tissue, pancreas tissue and kidney tissue sections of the rats were observed.
2、实验结果2. Experimental results
6周后,桑叶多组分混合物组大鼠血糖水平、胰岛素水平仅为模型对照组的26.06%、53.30%(P<0.05),与阳性药物二甲双胍对照组相当(P>0.05),具有较好的降血糖效果。After 6 weeks, the blood glucose levels and insulin levels of the rats in the mulberry leaf multi-component mixture group were only 26.06% and 53.30% of those in the model control group (P<0.05), which were comparable to those in the positive drug metformin control group (P>0.05). Good hypoglycemic effect.
6周后,桑叶多组分混合物组大鼠血清中的总胆固醇、甘油三酯、LDL-C及HDL-C分别是模型对照组的79.10%、49.50%、74.24%及1.33倍(P<0.05),且与空白对照组和阳性对照组均无显著性差异(P>0.05),说明桑叶多组分混合物能有效改善糖尿病大鼠脂质代谢紊乱。After 6 weeks, the total cholesterol, triglyceride, LDL-C and HDL-C in the serum of the rats in the mulberry leaf multi-component mixture group were 79.10%, 49.50%, 74.24% and 1.33 times that of the model control group, respectively (P< 0.05), and there was no significant difference with the blank control group and the positive control group (P>0.05), indicating that the multi-component mixture of mulberry leaves can effectively improve the lipid metabolism disorder in diabetic rats.
6周后,桑叶多组分混合物组大鼠血清中的抗氧化酶:超氧化物歧化酶SOD、谷胱甘肽过氧化物酶GSH-Px、过氧化氢酶CAT的活性分别是模型组的1.26倍、1.34倍、1.36倍(P<0.05),过氧化脂质丙二醛MDA水平则是模型组的84.06%(P<0.05),与阳性对照组无显著性差异(P>0.05)。桑叶多组分混合物通过提高糖尿病大鼠体内抗氧化酶活性、抑制脂质过氧化,改善糖尿病大鼠体内的氧化应激状态。After 6 weeks, the antioxidant enzymes in the serum of rats in the mulberry leaf multi-component mixture group: the activities of superoxide dismutase SOD, glutathione peroxidase GSH-Px, and catalase CAT were the same as those in the model group. 1.26 times, 1.34 times, and 1.36 times (P<0.05), and the lipid peroxidation MDA level was 84.06% of the model group (P<0.05), and there was no significant difference with the positive control group (P>0.05). . The multi-component mixture of mulberry leaves improves the oxidative stress state in diabetic rats by increasing the activity of antioxidant enzymes and inhibiting lipid peroxidation in diabetic rats.
6周后,桑叶多组分混合物组大鼠血清中的脂肪细胞因子:游离脂肪酸、TNF-α、瘦素和炎症因子C反应蛋白水平下降至模型对照组的68.63%、88.25%、84.15%和41.03%(P<0.05),脂肪细胞因子脂联素水平则升至模型组的1.16倍(P<0.05),且均与阳性对照二甲双胍组无明显差异(P>0.05)。桑叶提取物能够有效下调糖尿病大鼠体内脂肪细胞因子及C反应蛋白的异常高表达,改善胰岛素抵抗状态;并激活脂联素表达,增强胰岛素敏感性。After 6 weeks, the levels of adipocytokines: free fatty acids, TNF-α, leptin and inflammatory factor C-reactive protein in the serum of the rats in the mulberry leaf multi-component mixture group decreased to 68.63%, 88.25%, 84.15% of those in the model control group. and 41.03% (P<0.05), the level of adipocytokines adiponectin increased to 1.16 times that of the model group (P<0.05), and there was no significant difference between the two groups (P>0.05). Mulberry leaf extract can effectively down-regulate the abnormally high expression of adipocytokines and C-reactive protein in diabetic rats, improve insulin resistance, and activate the expression of adiponectin to enhance insulin sensitivity.
6周后,桑叶多组分混合物组大鼠血清中的肾功指标尿素氮、肌酐水平分别是模型组的71.31%、62.23%(P<0.05),且接近阳性对照组,无统计学差异(P>0.05)。After 6 weeks, the serum levels of urea nitrogen and creatinine in the mulberry leaf multi-component mixture group were 71.31% and 62.23% of the model group, respectively (P<0.05), and were close to the positive control group, with no statistical difference. (P>0.05).
6周后,桑叶多组分混合物组大鼠肝脏脂肪空泡明显减少,细胞排列有序、形态相对完整,肝小叶结构完整。胰岛细胞边界清楚,排列规则,胰岛细胞数量增多。肾小球体积轻度增大,肾小管未见透明变,肾小球及肾小管基底膜增厚明显减轻,肾组织的病理状态好转。提示桑叶提取物具有改善高脂饮食联合腹腔注射链脲佐菌素所致的糖尿病大鼠肝脏脂肪变性,并修复受损胰岛细胞,减轻持续高血糖对肾脏损害等作用。After 6 weeks, the hepatic fat vacuoles of the rats in the mulberry leaf multi-component mixture group were significantly reduced, the cells were arranged in an orderly manner, the morphology was relatively intact, and the hepatic lobule structure was intact. Islet cells have clear borders and regular arrangement, and the number of islet cells increases. The glomerular volume was slightly increased, the renal tubules did not show hyalinization, the thickening of the glomerular and renal tubular basement membranes was significantly reduced, and the pathological state of the renal tissue improved. It is suggested that mulberry leaf extract can improve liver steatosis caused by high-fat diet combined with intraperitoneal injection of streptozotocin in diabetic rats, repair damaged pancreatic islet cells, and reduce kidney damage caused by persistent hyperglycemia.
所以,本发明制得的桑叶多组分混合物能够通过提高糖尿病大鼠体内抗氧化酶活性,减轻肝脏、胰腺等组织的氧化应激损伤,改善胰岛素抵抗状态,增强胰岛素敏感性,从而有效降低糖尿病大鼠血糖水平,并改善大鼠脂质代谢紊乱,具有优异的降血糖效果。Therefore, the multi-component mixture of mulberry leaves prepared by the present invention can effectively reduce the oxidative stress damage of liver, pancreas and other tissues by increasing the activity of antioxidant enzymes in the body of diabetic rats, improving the state of insulin resistance, and enhancing insulin sensitivity. It can improve the blood sugar level of diabetic rats, and improve the lipid metabolism disorder in rats, with excellent hypoglycemic effect.
综上,本发明提供了一种桑叶DNJ提取物,它是以桑叶为原料,利用酸性的乙醇溶液提取所得;所述乙醇溶液浓度为65%~75%,乙醇溶液与桑叶的体积质量比为15~30mL/g。该方法中,提取的方式可以是浸提、超声波辅助酸性乙醇提取或微波辅助酸性乙醇提取。在本发明特定的提取条件下,所得桑叶DNJ提取物中DNJ的得率和纯度显著提高。本发明的桑叶DNJ提取物在制备活性成分只含桑叶DNJ,或者包含桑叶多糖、黄酮、DNJ混合物的降血糖药物中具有很好的前景。To sum up, the present invention provides a DNJ extract of mulberry leaves, which is obtained by using mulberry leaves as raw materials and extracted with an acidic ethanol solution; the concentration of the ethanol solution is 65% to 75%, and the volume of the ethanol solution and mulberry leaves is The mass ratio is 15 to 30 mL/g. In this method, the extraction method can be leaching, ultrasonic-assisted acidic ethanol extraction or microwave-assisted acidic ethanol extraction. Under the specific extraction conditions of the present invention, the yield and purity of DNJ in the obtained mulberry leaf DNJ extract are significantly improved. The mulberry leaf DNJ extract of the present invention has a good prospect in preparing a hypoglycemic drug containing only mulberry leaf DNJ or a mixture of mulberry leaf polysaccharides, flavonoids and DNJ as active ingredients.
特别的,本发明提供的由桑叶DNJ提取物、桑叶黄酮提取物、桑叶多糖提取物以1:6:8的比例组成桑叶多组分混合物能够通过提高糖尿病大鼠体内抗氧化酶活性,减轻肝脏、胰腺等组织的氧化应激损伤,改善胰岛素抵抗状态,增强胰岛素敏感性,从而有效降低糖尿病大鼠血糖水平,并改善大鼠脂质代谢紊乱,具有优异的降血糖效果,应用前景广阔。In particular, the mulberry leaf multi-component mixture provided by the present invention is composed of mulberry leaf DNJ extract, mulberry leaf flavonoid extract and mulberry leaf polysaccharide extract in a ratio of 1:6:8, which can improve antioxidant enzymes in diabetic rats by increasing the It can effectively reduce the oxidative stress damage of the liver, pancreas and other tissues, improve the state of insulin resistance, and enhance insulin sensitivity, thereby effectively reducing the blood sugar level in diabetic rats, and improving the lipid metabolism disorder in rats, with excellent hypoglycemic effect, application bright future.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010470759.1A CN111533680A (en) | 2020-05-28 | 2020-05-28 | Folium Mori extract and folium Mori multicomponent mixture with blood sugar lowering effect prepared from the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010470759.1A CN111533680A (en) | 2020-05-28 | 2020-05-28 | Folium Mori extract and folium Mori multicomponent mixture with blood sugar lowering effect prepared from the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111533680A true CN111533680A (en) | 2020-08-14 |
Family
ID=71974485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010470759.1A Pending CN111533680A (en) | 2020-05-28 | 2020-05-28 | Folium Mori extract and folium Mori multicomponent mixture with blood sugar lowering effect prepared from the same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111533680A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112546091A (en) * | 2020-12-16 | 2021-03-26 | 承德医学院 | Preparation process and detection method of mulberry leaf extract dropping pill |
CN112603941A (en) * | 2021-01-13 | 2021-04-06 | 湘潭市中心医院 | Preparation method of traditional Chinese medicine extract for regulating glycolipid metabolism |
CN113712206A (en) * | 2021-09-16 | 2021-11-30 | 湖南希尔天然药业有限公司 | A composition containing folium Mori DNJ and folium Mori peptide and its preparation method |
CN114539132A (en) * | 2022-04-13 | 2022-05-27 | 重庆工商大学 | A kind of hydrothermal acid-controlled alcohol extraction method of DNJ in mulberry leaves |
CN115316497A (en) * | 2022-08-15 | 2022-11-11 | 广东省农业科学院蚕业与农产品加工研究所 | Mulberry leaf extract, mandarin fish feed and application thereof |
CN116813815A (en) * | 2023-08-16 | 2023-09-29 | 重庆工商大学 | A method for hydrothermal and acid-controlled degradation of polysaccharides extracted from mulberry leaves and its antioxidant application |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101209284A (en) * | 2007-12-24 | 2008-07-02 | 天津大学 | Method for continuously extracting active ingredients of alkaloids, flavonoids and polysaccharides from mulberry leaves |
CN101412703A (en) * | 2008-11-17 | 2009-04-22 | 江苏科技大学 | Composite extracting technique for coproduction of mulberry tea flavone, polysaccharide and alkaloid |
CN102101840A (en) * | 2011-02-15 | 2011-06-22 | 杭州惠远实业有限公司 | Method for extracting and separating high-purity 1-Deoxynojirimycin from folium mori |
CN103755623A (en) * | 2014-01-03 | 2014-04-30 | 广州军区广州总医院 | Response surface method optimized method for extracting 1-deoxynojirimycin in mulberry leaves with acidic ethanol solution |
CN107536871A (en) * | 2017-09-13 | 2018-01-05 | 中国科学院动物研究所 | A kind of preparation method for Traditional Chinese medicine for decreasing blood sugar extract |
CN114539132A (en) * | 2022-04-13 | 2022-05-27 | 重庆工商大学 | A kind of hydrothermal acid-controlled alcohol extraction method of DNJ in mulberry leaves |
-
2020
- 2020-05-28 CN CN202010470759.1A patent/CN111533680A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101209284A (en) * | 2007-12-24 | 2008-07-02 | 天津大学 | Method for continuously extracting active ingredients of alkaloids, flavonoids and polysaccharides from mulberry leaves |
CN101412703A (en) * | 2008-11-17 | 2009-04-22 | 江苏科技大学 | Composite extracting technique for coproduction of mulberry tea flavone, polysaccharide and alkaloid |
CN102101840A (en) * | 2011-02-15 | 2011-06-22 | 杭州惠远实业有限公司 | Method for extracting and separating high-purity 1-Deoxynojirimycin from folium mori |
CN103755623A (en) * | 2014-01-03 | 2014-04-30 | 广州军区广州总医院 | Response surface method optimized method for extracting 1-deoxynojirimycin in mulberry leaves with acidic ethanol solution |
CN107536871A (en) * | 2017-09-13 | 2018-01-05 | 中国科学院动物研究所 | A kind of preparation method for Traditional Chinese medicine for decreasing blood sugar extract |
CN114539132A (en) * | 2022-04-13 | 2022-05-27 | 重庆工商大学 | A kind of hydrothermal acid-controlled alcohol extraction method of DNJ in mulberry leaves |
Non-Patent Citations (9)
Title |
---|
季涛,等: "基于α-葡萄糖苷酶抑制活性评价桑叶多组分药效相互作用研究", 《中国中药杂志》 * |
张月,等: "桑叶黄酮提取物制备及其体外抗氧化作用研究", 《中国食品添加剂》 * |
杨小蓉,等: "桑叶DNJ的分离纯化及其生物活性研究进展", 《食品工业》 * |
玄光善,等: "桑叶有效成分降糖作用研究", 《食品科学》 * |
王兴婷,等: "桑叶DNJ提取物体外降血糖及抗氧化作用研究", 《食品科技》 * |
王德萍,等: "桑叶多组分协同降血糖作用", 《现代预防医学》 * |
苏楠,等: "响应面分析法优化桑叶中1-脱氧野尻霉素的稀酸乙醇浸提工艺", 《中国实验方剂学杂志》 * |
贺伟强,等: "桑叶活性成分药理作用研究进展", 《北方园艺》 * |
鲁慧,等: "新疆桑叶生物活性成分种属与季节差异性研究", 《食品科技》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112546091A (en) * | 2020-12-16 | 2021-03-26 | 承德医学院 | Preparation process and detection method of mulberry leaf extract dropping pill |
CN112603941A (en) * | 2021-01-13 | 2021-04-06 | 湘潭市中心医院 | Preparation method of traditional Chinese medicine extract for regulating glycolipid metabolism |
CN113712206A (en) * | 2021-09-16 | 2021-11-30 | 湖南希尔天然药业有限公司 | A composition containing folium Mori DNJ and folium Mori peptide and its preparation method |
CN114539132A (en) * | 2022-04-13 | 2022-05-27 | 重庆工商大学 | A kind of hydrothermal acid-controlled alcohol extraction method of DNJ in mulberry leaves |
CN114539132B (en) * | 2022-04-13 | 2023-09-12 | 重庆工商大学 | DNJ method for hydrothermally acid-controlled alcohol extraction of mulberry leaves |
CN115316497A (en) * | 2022-08-15 | 2022-11-11 | 广东省农业科学院蚕业与农产品加工研究所 | Mulberry leaf extract, mandarin fish feed and application thereof |
CN115316497B (en) * | 2022-08-15 | 2023-05-09 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of mulberry leaf extract, mandarin fish feed and application thereof |
CN116813815A (en) * | 2023-08-16 | 2023-09-29 | 重庆工商大学 | A method for hydrothermal and acid-controlled degradation of polysaccharides extracted from mulberry leaves and its antioxidant application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111533680A (en) | Folium Mori extract and folium Mori multicomponent mixture with blood sugar lowering effect prepared from the same | |
CN104311688B (en) | Method for extracting and separating dendrobium nobile polysaccharide and total alkali | |
CN108047343B (en) | Preparation method and application of total polysaccharide of Ibemuelae | |
CN104987433A (en) | Preparation method of RG-I type lycium barbarum pectin with anti-aging activity | |
CN102038720A (en) | Fuscoporia obliqua active ingredients capable of lowering blood sugar and preparation method and application of fuscoporia obliqua active ingredients | |
CN102936292A (en) | Preparation method of lycium barbarum polysaccharide having high antioxidant activity | |
CN110101728B (en) | Combined extraction method of purslane polysaccharide and total flavonoids based on micelle medium treatment | |
CN101735644A (en) | Method for extracting ipomoes batatas L. anthocyanidins | |
CN114177218A (en) | A kind of mulberry leaf extract rich in 1-deoxynojirimycin and preparation method thereof | |
CN106221283A (en) | A kind of extracting method of black rice anthocyanin | |
CN110790848A (en) | Preparation method and application of total seabuckthorn polysaccharide | |
CN110974870B (en) | A kind of preparation method of mulberry polyphenols crude extract | |
CN114773495B (en) | Method for preparing Fuzhuan tea polysaccharide with blood sugar and blood lipid reducing functions | |
CN113368127B (en) | Selenium polysaccharide and preparation method and application thereof | |
CN114209721A (en) | A kind of Moringa leaf polyphenol-polysaccharide composition for reducing blood sugar and lipid control, and preparation method and application thereof | |
CN119119313A (en) | Preparation method and application of fresh Dendrobium officinale refined polysaccharide | |
CN1248992C (en) | Preparation of oligomer and monomer from tannin by catalytic hydrogen degradation | |
CN117467032A (en) | Golden fungus fruiting body extract and preparation method thereof | |
CN114712416B (en) | Method for efficiently and synchronously extracting flavone, alkaloid and polyphenol in lotus leaves by using water-borne method | |
CN103285027B (en) | Application of chroogomphus rutilus mycelium polysaccharide in preparation of blood sugar reducing medicines | |
CN112870298B (en) | Dendrobium officinale stock solution as well as preparation method and application thereof | |
CN105542030A (en) | Method for extracting water-soluble beta-glucan from Phellinus sporocarp | |
CN105395927B (en) | Highland barley bran extract is preparing the application in alpha-glucosidase activity inhibitor | |
CN113729224A (en) | Preparation method and application of roxburgh rose extract rich in SOD and various nutritional ingredients | |
CN111777499A (en) | Curcumin extraction and purification method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |
|
RJ01 | Rejection of invention patent application after publication |